These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8091344)

  • 21. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
    Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
    Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of leukotrienes in post-allergic propranolol-induced bronchoconstriction in guinea-pigs.
    Fujimura M; Songür N; Ishiura Y; Mizuhashi K; Myou S; Matsuda T
    Clin Exp Allergy; 1997 Oct; 27(10):1219-26. PubMed ID: 9383263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
    Burgers JA; Bruynzeel PL; Mengelers HJ; Kreukniet J; Akkerman JW
    J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs.
    Sugimoto Y; Nakayama Y; Kishida H; Hayakawa T; Fujiwara R; Kamei C
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):547-52. PubMed ID: 9442478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
    Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor antagonists.
    Saunders RN; Handley DA
    Annu Rev Pharmacol Toxicol; 1987; 27():237-55. PubMed ID: 3555317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of Yangambin - a naturally occurring platelet-activating factor (PAF) receptor antagonist - on anaphylactic shock in rats.
    Ribeiro R; Carvalho FA; Barbosa-Filho JM; Cordeiro RS; Tibiriçá EV
    Phytomedicine; 1996 Nov; 3(3):249-56. PubMed ID: 23195079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of prophylactic anti-asthma drugs on PAF-induced platelet accumulation in the thorax of the guinea pig.
    Smith D; Sanjar S; Morley J
    Jpn J Pharmacol; 1989 Oct; 51(2):161-6. PubMed ID: 2593374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor in late asthmatic response.
    Nakamura T; Morita Y; Kuriyama M; Ishihara K; Ito K; Miyamoto T
    Int Arch Allergy Appl Immunol; 1987; 82(1):57-61. PubMed ID: 3804454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Agonists and antagonists of the platelet activating factor (PAF). II].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(2):439-40. PubMed ID: 2100870
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of rhesus monkey airway and cutaneous responses to platelet-activating factor (PAF) (AGEPC) with the anti-PAF agent SRI 63-072.
    Patterson R; Harris KE; Lee ML; Houlihan WJ
    Int Arch Allergy Appl Immunol; 1986; 81(3):265-8. PubMed ID: 3770978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacologic basis of therapy for cerebral ischemia].
    Krieglstein J; Peruche B
    Arzneimittelforschung; 1991 Mar; 41(3A):303-9. PubMed ID: 1859500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAF inhibitors of microbial origin. Studies on diketopiperazine derivatives.
    Yoshida K; Okamoto M; Shimazaki N; Hemmi K
    Prog Biochem Pharmacol; 1988; 22():66-80. PubMed ID: 2457219
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor.
    Morley J; Sanjar S; Boubekeur K; Aoki S; Kristersson A
    Agents Actions Suppl; 1988; 23():187-94. PubMed ID: 3262989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor in cardiovascular stress situations.
    Rabinovici R; Yue TL; Feuerstein G
    Lipids; 1991 Dec; 26(12):1257-63. PubMed ID: 1819713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a case for PAF antagonists in the treatment of ischemic states?
    Braquet P; Paubert-Braquet M; Koltai M; Bourgain R; Bussolino F; Hosford D
    Trends Pharmacol Sci; 1989 Jan; 10(1):23-30. PubMed ID: 2688213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of platelet activating factor in allergic respiratory disease.
    Page CP
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):99S-106S. PubMed ID: 2268512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor and cytokine interactions in shock.
    Hosford D; Paubert-Braquet M; Braquet P
    Resuscitation; 1989 Dec; 18(2-3):207-18. PubMed ID: 2555874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.